Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Talphera Inc., 2 years.
Talphera Inc.
Director
Cue Biopharma Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Talphera Inc. | Grant or award | +5,100 | — | — |
| Feb 4, 2026 | aTyr Pharma Inc. | Open-market sale | −1,558 | $0.98 | $1,527 |
| Feb 3, 2026 | aTyr Pharma Inc. | Option exercise | +3,750 | — | — |
| Oct 23, 2025 | Talphera Inc. | Grant or award | +4,267 | — | — |
| Feb 4, 2025 | aTyr Pharma Inc. | Open-market sale | −1,254 | $3.78 | $4,740 |
| Feb 3, 2025 | aTyr Pharma Inc. | Option exercise | +3,750 | — | — |
| Jun 24, 2024 | Talphera Inc. | Grant or award | +2,174 | — | — |
| May 31, 2024 | aTyr Pharma Inc. | Open-market purchase | +5,000 | $1.79 | $8,950 |
| Feb 6, 2024 | aTyr Pharma Inc. | Open-market sale | −1,590 | $1.69 | $2,687 |
| Feb 5, 2024 | aTyr Pharma Inc. | Option exercise | +3,750 | — | — |
| Oct 10, 2023 | Talphera Inc. | Grant or award | +581 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.